The downregulation of ACE2 by viral infection and/or S1 protein could be one of the mechanisms of recruitment of inflammatory cells to the lung, which promoted pulmonary fibrosis and ARDS in COVID-19 patients (13, 38, 39). Here, ACE2 is linked to pulmonary fibrosis.